格隆汇11月20日｜辉瑞公司周三表示，已任命该公司资深人士Chris Boshoff担任研发主管。Boshoff 将从1月1日起担任首席科学官，负责所有治疗领域的研发工作。Boshoff 在过去一年中领导了辉瑞的抗癌医药研究和营销工作，监督了公司与Seagen的整合。辉瑞前首席科学官Mikael Dolsten是COVID-19疫苗研发的关键人物，他在辉瑞工作了15年多后于今年早些时候卸任。活跃投资者Starboard批评辉瑞管理层在大额收购上花费过多，却未能从这些交易或内部研发中生产出盈利的新药。

海量资讯、精准解读，尽在新浪财经APP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.